Transradial Primary Percutaneous Coronary Intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Bleeding complications are a major concern in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI).
• Access site bleeding is a frequent cause of morbidity and mortality in these patients.
• Advances in antithrombotic and antiplatelet therapies have not eliminated bleeding risks.

Purpose of the Study:

• To evaluate the efficacy and safety of Transradial Access (TRA) compared to Transfemoral Access (TFA) in patients with STEMI undergoing PPCI.
• To assess the impact of TRA on bleeding and vascular complications.
• To determine the effect of TRA on cardiac mortality in STEMI patients.

Main Methods:

• Comparative analysis of patients undergoing PPCI for STEMI via TRA versus TFA.
• Assessment of bleeding events, vascular complications, and procedural outcomes.
• Evaluation of cardiac mortality rates between the two access groups.

Main Results:

• Transradial access (TRA) PPCI is associated with a significant reduction in bleeding and vascular complications compared to Transfemoral Access (TFA).
• TRA PPCI demonstrated reduced cardiac mortality in STEMI patients.
• High-risk patient populations may experience particular benefits from TRA.

Conclusions:

• Transradial access is a safer alternative to transfemoral access for PPCI in STEMI patients, leading to fewer complications and improved survival.
• Developing radial skills is crucial for achieving procedural success comparable to TFA.
• TRA should be strongly considered for STEMI PPCI, especially in high-risk individuals.